Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia

Overview of attention for article published in Journal of Gastroenterology & Hepatology, July 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 3 X users
facebook: 1 Facebook page

guideline: 1 clinical guideline source

Readers on

mendeley: 113 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

Guía GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodología GRADE

Clinical guideline published by Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) on 01 Aug 2020

The primary objective of GETECCU is to study and research Inflammatory Bowel Disease (IBD) and to seek the standardization of clinical-therapeutic criteria in its diagnosis and treatment.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.